Russian Federation
Gout is a systemic disease associated with the deposition of sodium monaurate crystals in various tissues, which leads to the development of inflammation. Given that the main clinical manifestation of gout is acute arthritis, it is necessary to carry out differential diagnosis with other diseases with similar clinical symptoms. A reliable diagnosis can be made when sodium monaurate crystals are detected in synovial fluid, but this is not always available in practice. Therefore, it is necessary to use a comprehensive assessment: clinical, laboratory, instrumental. Due to the frequent concomitant metabolic disorders that occur in gout, a multidisciplinary approach to the management of such patients is important.
gout, hyperuricemia, treatment of chronic gouty arthritis, tofuses, clinical case.
1. Nasonova V.A., Barskova V.G. Rannie diagnostika i lechenie podagry - nauchno obosnovannoe trebovanie uluchsheniya trudovogo i zhiznennogo prognoza bol'nyh. Nauchno-prakticheskaya revmatologiya 2004;1:5-7.
2. Shostak N.A., Loginova T.K., Homenko V.V., Ryabkova A.A. Podagra - ostryy podagricheskiy artrit i vozmozhnosti ego lecheniya // RMZh. - 2003. - T.11, № 23. 14.
3. Suhih Zh.L., Shtonda M.V., Petrov S.A.,Vorob'eva E.P. Podagra: sovremennye aspekty diagnostiki i lecheniya. Mezhdunarodnye obzory: Klinicheskaya praktika i zdorov'e. 2014. №4. 79-89.
4. Eliseev M.S. Novye mezhdunarodnye rekomendacii po diagnostike i lecheniyu podagry: prostye otvety na prostye voprosy. Nauchno-prakticheskaya revmatologiya. - 2014. - № 52. - S. 141-146.
5. Kambachokova Z.A., Aramisova R.M. Trudnosti vedeniya pacientov s podagroy na fone komorbidnyh sostoyaniy. Revmatologiya. Trudnyy pacient. 2018. Tom №16, №6. 46-52.
6. Maksudova, A.N. Podagra / A.N. Maksudova, I.G. Salihov, R.A. Habirov. - M.: MEDpress-inform, 2008. - S. 96.
7. Hyon, K. Prevalence of the Metabolic Syndrome in Patients With Gout: The Third National Health and Nutrition Examination Survey / K. Hyon, S. Ford [et al.] // Arthritis & Rheumatism. - 2007. - Vol. 57. - № 1. - R. 109-115. 8.
8. Rho, Y.H. The prevalence of metabolic syndrome in patients with gout: a multicenter study / Y.H. Rho, S.J. Choi, Y.H. Lee [et al.]// J. Korean. Med. Sci. - 2005. - Vol. 20, issue 6. - R. 1029-1033.
9. Arromdee E., Michet C.J., Crowson C.S. et al. Epidemiology of Gout: Is the Incidence Rising? J Rheum 2002;29:2403-6.
10. Gutman A.B. The past four decades of progress in the knowledge of gout, with an assessment of the present status. Arthr Rheum 1973;16:431-45.
11. Barskova V.G., Nasonova V.A., Yakunina I.A. i dr. Retrospektivnyy analiz prichin pozdney diagnostiki podagry. Klin gerontol 2004;6:12-7.
12. Zhang W., Doherty M., Pascual-Gomez E. et al. EULAR evidence based recommendation for the diagnosis and management of gout. Ann Rheum Dis 2005;64(Suppl. III):501.
13. Barskova V.G., Eliseev M.S. Bol'naya hronicheskoy podagroy: kommentarii k techeniyu bolezni. Klinicheskiy razbor. Sovremennaya revmatologiya. 2010. №1. 32-38.
14. Shamsutdinova N.G., Yakupova S.P. Podagricheskiy artrit v obschevrachebnoy praktike. Vestnik sovremennoy klinicheskoy mediciny. 2014. Tom №1, prilozhenie №2. 208-211.
15. Barskova, V.G. V pomosch' molodomu revmatologu: na prieme bol'noy s podagricheskim artritom. Sovremennaya revmatologiya. 2010. № 3. S.53-57.
16. Nasonova, E.L. Revmatologiya: nacional'noe rukovodstvo/ E.L. Nasonova, V.A. Nasonova. - M.: GEOTAR-Media, 2008. - S. 372-380.
17. Karateev A.E., Nasonov E.L., Ivashkin V.T. s soavt. Racional'noe ispol'zovanie nesteroidnyh protivovospalitel'nyh preparatov. Klinicheskie rekomendacii. Nauchno-prakticheskaya revmatologiya. 2018; 56(S1): 1-29.
18. Simon L.S., Lanza F.L., Lipsky P.E. et al. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum. 1998;41(9):1591-602.
